Showing results (771-780 of 6,300) with videos related to
Sort By:
Pageof 630
Diabetes, Obesity & Metabolism|November 27, 2014
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trialM A Abdul-Ghani, C Puckett, C Triplitt, et al.Diabetes, Obesity & Metabolism|December 4, 2014
Peripheral arterial disease and revascularization of the diabetic footR O Forsythe, J Brownrigg, R J HinchliffeDiabetes, Obesity & Metabolism|November 20, 2014
Effects of acute exercise on pancreatic endocrine function in subjects with type 2 diabetesS H Knudsen, K Karstoft, K Winding, et al.Diabetes, Obesity & Metabolism|November 1, 2014
Therapeutically interchangeable? A study of real-world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records dataP Levin, W Wei, R Miao, et al.Diabetes, Obesity & Metabolism|November 26, 2014
Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double-blind, crossover studyS Sha, D Polidori, K Farrell, et al.Diabetes, Obesity & Metabolism|November 17, 2020
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)Arndís F Ólafsdóttir, Jan Bolinder, Tim Heise, et al.Diabetes, Obesity & Metabolism|November 17, 2020
COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admissionHarald Sourij, Faisal Aziz, Alexander Bräuer, et al.Diabetes, Obesity & Metabolism|November 20, 2020
Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trialJaehyun Bae, Ji Hye Huh, Minyoung Lee, et al.Diabetes, Obesity & Metabolism|September 9, 2020
Effect of fully automated closed-loop insulin delivery using faster aspart versus standard aspart on gluco-regulatory hormones in type 2 diabetesDavid Herzig, David Studer, Christos T Nakas, et al.Diabetes, Obesity & Metabolism|September 9, 2020
Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking programTaufiq Salahuddin, Vanessa Richardson, Demetria M McNeal, et al.Pageof 630